Pharmaceutical Companies
Idorsia Ltd
π¨πSwitzerland
Korro Bio Ops, Inc.
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $462.1M
- Website
- -
Q32 Bio Inc
πΊπΈUnited States
- Ownership
- -
- Established
- 1961-01-01
- Employees
- -
- Market Cap
- $456.1M
- Website
- -
MAXCYTE INC.
πΈπͺSweden
C4 Therapeutics
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- 145
- Market Cap
- $445.8M
- Website
- -
C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small...
Foghorn Therapeutics
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- 116
- Market Cap
- $439.8M
- Website
- -
Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its...
Taysha Gene Therapies
πΊπΈUnited States
Botanix Pharmaceuticals Inc.
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $436.4M
- Website
- -
XERIS PHARMACEUTICALS INC
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $429.1M
- Website
- -
Tourmaline Bio
πΊπΈUnited States
- Ownership
- Public, Subsidiary
- Established
- 2002-01-01
- Employees
- 44
- Market Cap
- $428.2M
- Website
- http://www.tourmalinebio.com
Tourmaline Bio, Inc. is a late-stage clinical biotechnology company, which engages in the development of medicines for patients with life-altering immune diseases. It offers the TOUR006. The company was founded by Sandeep Kulkarni on...
